NBY vs OGEN

Comparison between Stablecoin Development Corp (NBY, Company) and Oragenics Inc (OGEN, Company).

Both NBY and OGEN are from the Healthcare sector.

NBY vs OGEN - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NBY(COMPANY)	OGEN(COMPANY)
Market Cap	$2.40M	$2.40M
Max Drawdown	N/A	100.00%
Sharpe Ratio	N/A	-1.37
5Y Beta	N/A	0.00
Industry	Biotechnology	Biotechnology
P/E Ratio	0.00	-0.25
Forward P/E	42.02	N/A
PEG Ratio	N/A	0.00
Debt to Equity	0.00%	0.00%
P/S Ratio	N/A	89.28
P/B Ratio	N/A	0.40

Market Cap

Winner

NBY

$2.40M

OGEN

$2.40M

Max Drawdown

NBY

N/A

OGEN

100.00%

Sharpe Ratio

NBY

N/A

OGEN

-1.37

5Y Beta

NBY

N/A

OGEN

0.00

Industry

NBY

Biotechnology

OGEN

Biotechnology

P/E Ratio

NBY

0.00

Winner

OGEN

-0.25

Forward P/E

NBY

42.02

OGEN

N/A

PEG Ratio

NBY

N/A

OGEN

0.00

Debt to Equity

NBY

0.00%

OGEN

0.00%

P/S Ratio

NBY

N/A

OGEN

89.28

P/B Ratio

NBY

N/A

OGEN

0.40

NBY vs OGEN - Historical Returns

Returns include dividend reinvestment.

Period	NBY	OGEN
1 month	N/A	-1.51%
3 months	N/A	-13.45%
6 months	N/A	-29.11%
1 year	N/A	-83.48%
5 years(CAGR)	N/A	-78.62%
10 years(CAGR)	N/A	-62.15%
Max(CAGR)	N/A	-48.40%

NBY

N/A

OGEN

-1.51%

NBY

N/A

OGEN

-13.45%

NBY

N/A

OGEN

-29.11%

NBY

N/A

OGEN

-83.48%

5Y(CAGR)

NBY

N/A

OGEN

-78.62%

10Y(CAGR)

NBY

N/A

OGEN

-62.15%

Max(CAGR)

NBY

N/A

OGEN

-48.40%

NBY vs OGEN - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	NBY	OGEN
2026	+0.00%	-29.58%
2025	N/A	-92.75%
2024	N/A	-94.55%
2023	N/A	-19.58%
2022	N/A	-77.77%
2021	N/A	-14.21%
2020	N/A	-11.96%
2019	N/A	-40.25%
2018	N/A	-62.00%
2017	N/A	-54.90%
2016	N/A	-60.58%
2015	N/A	+74.42%
2014	N/A	-68.93%
2013	N/A	+4.07%
2012	N/A	+140.00%
2011	N/A	-66.33%
2010	N/A	-53.13%
2009	N/A	+15.38%
2008	N/A	-43.18%
2007	N/A	-63.06%
2006	N/A	+168.29%
2005	N/A	-89.25%
2004	N/A	-9.41%